MindWalk Holdings (HYFT) Inventory Average (2020 - 2026)
MindWalk Holdings (HYFT) reported Inventory Average of $173379.1 for Q1 2026, up 14.0% year-over-year from $152086.8 in Q1 2025, and down 54.62% quarter-over-quarter from $382073.1 in Q4 2025.
MindWalk Holdings (HYFT) Inventory Average (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Inventory Average data on file, last reported at $173379.1 in Q1 2026.
- Inventory Average for Q1 2026 came in at $173379.1, up 14.0% year-over-year; the trailing twelve-month figure through Jan 2026 was $173379.1 (up 14.0% YoY), and the FY2025 annual result was $1.5 million, down 0.6% from the prior year.
- Inventory Average fell to $173379.1 in Q1 2026 per HYFT's latest filing, from $382073.1 in the prior quarter.
- Over five years, Inventory Average peaked at $1.2 million in Q2 2022 and troughed at -$217394.6 in Q1 2024.
- A 5-year average of $561185.2 and a median of $613111.7 in 2022 frame the typical range for Inventory Average.
- On a YoY basis, Inventory Average climbed as much as 456.74% in 2024 and fell as far as 1701.68% in 2024.
- A 5-year view of Inventory Average shows it stood at $613111.7 in 2022, then slumped by 107.87% to -$48259.1 in 2023, then soared by 456.74% to $172158.5 in 2024, then soared by 121.93% to $382073.1 in 2025, then plunged by 54.62% to $173379.1 in 2026.
- Business Quant data shows HYFT's Inventory Average at $173379.1 in Q1 2026, $382073.1 in Q4 2025, and $926788.1 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 173,379.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 173,379.13 |
| Oct 31, 2025 | 382,073.13 |
| Jul 31, 2025 | 926,788.06 |
| Apr 30, 2025 | 825,218.30 |
| Jan 31, 2025 | 152,086.83 |
| Oct 31, 2024 | 172,158.47 |
| Jul 31, 2024 | 897,959.58 |
| Apr 30, 2024 | 599,039.38 |
| Jan 31, 2024 | -217,394.58 |
| Oct 31, 2023 | -48,259.13 |
| Jul 31, 2023 | 740,617.55 |
| Apr 30, 2023 | 738,237.43 |
| Jan 31, 2023 | -12,066.24 |
| Oct 31, 2022 | 613,111.74 |
| Jul 31, 2022 | 1.24 Mn |
| Apr 30, 2022 | 1.24 Mn |
| Jan 31, 2022 | 1.11 Mn |
| Oct 31, 2021 | 1.03 Mn |
| Jul 31, 2021 | 1.01 Mn |
| Apr 30, 2021 | 956,749.42 |